In vitro and in vivo activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphoma
- Haematologica. 2018 Nov;103(11):e537-e540. doi: 10.3324/haematol.2018.189241.
Affiliations
- 1. Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL) L'Hospitalet, Barcelona, Catalonia.
- 2. Quimatryx, San Sebastian.
- 3. Oncomatryx, Arteaga Auzoa, 43, Derio.
- 4. Department of Organic Chemistry I, Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), San Sebastián.
- 5. Department of Organic Chemistry I, Centro de Innovación en Química Avanzada (ORFEO-CINQA), Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), Donostia International Physics Center (DIPC), San Sebastián.
- 6. Mass Spectrometry Platform, CIC biomaGUNE, San Sebastian.
- 7. Laboratory of Translational Research, Catalan Institute of Oncology (ICO), IDIBELL L'Hospitalet, Barcelona, Catalonia.
- 8. Department of Hematology, ICO-Hospital Duran i Reynals, IDIBELL, University of Barcelona, L'Hospitalet, Barcelona, Catalonia.
- 9. Department of Hematology, ICO-Hospital Universitari Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Catalonia.
- 10. Pathology Service, Fundación Jiménez Díaz, Madrid.
- 11. Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL) L'Hospitalet, Barcelona, Catalonia [email protected].
- 12. Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid.
- 13. Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), L'Hospitalet, Catalonia.
- 14. Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.
PMID: 29880608
DOI: 10.3324/haematol.2018.189241
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-